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http:WHAT THIS PAPER ADDS
This is the ﬁrst study examining UPR-activation in human rupture-prone carotid plaques, and the proapoptotic
UPR-CHOP signaling pathway was identiﬁed as a potential inducer of apoptosis in vascular cells. On the basis of
these results, acute cerebrovascular events (stroke and TIA) are now joined with acute coronary syndromes as
clinical events that warrant intense research into development and implementation of anti-apoptotic strategies,
including targeting activation of the UPR-PERK/CHOP-branch speciﬁcally. That, in turn, may relieve ER-stress-
induced apoptosis and thereby has the potential to reduce plaque progression/ruptures in cardiovascular disease.Objective: To analyze expression of keystone markers of apoptosis and the proapoptotic signaling pathway
“unfolded protein response” (UPR) in rupture-prone plaques of the human carotid artery.
Methods: Plaque specimens were obtained during endarterectomy for high-grade carotid stenosis, and were
formalin-ﬁxed. Ten specimens were identiﬁed that exhibited criteria of advanced rupture-prone atherosclerotic
plaques, and histological and immunohistological analysis of markers of apoptosis (cleaved Caspase-3, TUNEL)
and UPR (KDEL, ATF3, CHOP, CHAC-1) was performed. In addition, co-localization of apoptosis and UPR-activation
was assessed by double-immunohistochemistry.
Results: The mean size of the necrotic core was 44  7% and the mean minimum/representative thicknesses of
the ﬁbrous cap were 129  39 mm/280  60 mm, respectively. Each specimen fulﬁlled at least two of the criteria
for rupture-prone plaques. Semi-quantitative analysis of immunohistochemistry showed a signiﬁcant increase in
cleaved Caspase-3-positive (1923  93 cells/mm2) and TUNEL-positive cells (1387  66 cells/mm2) when
compared with control tissue. Furthermore, expression of UPR-markers KDEL, AFT3 and CHOP was signiﬁcantly
increased (1175  40 cells/mm2, 1971  69 cells/mm2 and 2173  120 cells/mm2, respectively). Co-localization
of UPR-activation with apoptosis was conﬁrmed by double-immunohistochemistry, and lesional macrophages
were identiﬁed as the primary cell-type involved.
Conclusion: For the ﬁrst time, activation of the proapoptotic signaling pathway UPR has been identiﬁed in
advanced rupture-prone plaques of the human carotid artery. This provides additional evidence for adding UPR to
the potential targets for controlling plaque apoptosis and thereby preventing plaque progression/rupture.
 2014 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
Article history: Received 3 March 2014, Accepted 13 June 2014, Available online 22 July 2014
Keywords: Apoptosis, Immunohistochemistry, Carotid stenosis, Atherosclerotic plaque, Unfolded protein
responseINTRODUCTION
Plaque rupture is the most common cause of coronary
artery thrombosis and serves as the pathomorphological
correlate for acute coronary syndrome.1 In the cerebro-
vascular circulation, plaque rupture of carotid lesions hasorweiler and I. Grechowa contributed equally to this work.
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//dx.doi.org/10.1016/j.ejvs.2014.06.038been identiﬁed as being positively associated with recent
TIA (transitory ischemic attack) and stroke.2,3 Atheroscle-
rosis as the underlying disease is a progressive inﬂamma-
tory process triggered by retention of lipids in the arterial
wall,4 leading to multifocal lesion development and for-
mation of vulnerable plaques, the precursor of plaque
rupture, being characterized by a large necrotic core
(>30% of plaque) and a thin ﬁbrous cap (<65 mm).5
Increased apoptosis of lesional macrophages is one of
the molecular mechanisms that leads to increased size of
the necrotic core and thinning of the ﬁbrous cap.6 Among
several triggers of apoptosis, ER (endoplasmic reticulum)-
stress was identiﬁed as a potent inducer of macrophage
apoptosis.7
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tween the load of unfolded and misfolded proteins in the
ER and the capacity of the cellular machinery that copes
with that load and sets a compensatory mechanism, the
unfolded protein response (UPR), in motion, which reduces
protein load and increases folding capacity. If cellular ho-
meostasis cannot be re-established, programmed cell death
(apoptosis) is initiated.8
This is achieved by phosphorylation of the ER-membrane
bound protein kinase RNA-like ER kinase (PERK), which, in
turn, phosphorylates eukaryotic translation initiation factor
2 alpha (eIF2a), which then promotes translation of acti-
vating transcription factor 4 (ATF4) and subsequent induc-
tion of CHOP (C/EBP-homologous protein).9 CHOP itself
causes proapoptotic changes, such as downregulation of
BCL-2 and activation of calcium signaling pathways with
subsequent induction of FAS death receptor.10
Robust evidence has accumulated from animal models of
ApoE-deﬁcient mice that activation of the PERK-CHOP
branch of the unfolded protein response occurs in athero-
sclerotic lesions and promotes necrotic core formation.11e15
Interestingly, only one study is available that has examined
activation of the PERK-CHOP branch in a human specimen
(coronary artery16), but UPR-activation has not been stud-
ied so far in carotid plaques. Therefore, the aim of this study
was to analyze activation of the PERK-CHOP branch of the
UPR in human advanced rupture-prone carotid lesions.
METHODS
Carotid artery specimens
Carotid artery specimens were obtained from patients un-
dergoing carotid endarterectomy for high-grade stenosis of
the internal carotid artery at University Medical Center,
Johannes-Gutenberg University, Mainz, Germany. The
excised plaques were ﬁxed in 4% formalin (Roth, Karlsruhe,
Germany) immediately after retrieval in the operating
room, and subsequently embedded in parafﬁn wax. The
plaque cylinder was manually trimmed to an approximately
3 mm specimen containing the segment with maximum
lumen reduction, which was subsequently cut into 3 mm
transverse sections (perpendicular to the lumen), mounted
on Superfrost Plus slides (Menzel, Thermo Scientiﬁc,
Braunschweig, Germany) and deparafﬁnized in xylene. Ca-
rotid specimens were analyzed by histology and 10 speci-
mens complying with criteria for rupture-prone plaques
were chosen for further detailed analysis. Control speci-
mens of common carotid artery and common femoral arteryTable 1. List of antibodies, suppliers and concentration used.
Antigen Isotype Clone
CD68 Mouse IgG3 PG-M1
Actin Mouse IgG2A 1A4
KDEL Mouse IgG2A 10C3
ATF-3 Rabbit IgG Polyclonal
CHAC-1 Rabbit IgG Polyclonal
cCaspase-3 Rabbit monoclonal Asp175 (5A1)
CHOP Rabbit IgG Polyclonalwere obtained from patients without clinical evidence of
atherosclerotic disease (vascular trauma, organ donor).
Clinical data were recorded for each patient. The use of
human tissue for this study was approved by the local ethics
committee and consent was obtained from the patients.
Histopathology
For morphological analysis, every 10th section was stained
with hematoxylin and eosin (H&E, Gill’s No.3, Polyscience
Inc. Eppelheim, Germany) as well as Masson-Goldner
(Roth). From those sets of 10 sections each, ﬁve sets con-
taining the area of maximum lumen reduction were
selected and ﬁve representative overviews of H&E staining
of total plaque area of each cylinder were taken with a
digital camera-equipped microscope (ZEISS Axioplan,
Oberkochen, Olympus XC30, Hamburg, Germany). Cap
thickness, area of the necrotic core and total area of the
plaque were measured using CellSens Imaging Software
(Olympus). The necrotic core was deﬁned as amorphous
material containing cholesterol crystals. The ﬁbrous cap was
identiﬁed, and the thinnest part (minimum cap thickness)
and the part with a thickness considered to be most
representative of the cap as a whole (representative cap
thickness) were measured and averaged.17 In addition,
plaques were graded according to the AHA-classiﬁcation.18
Immunohistochemistry
For each antibody, at least ﬁve representative sections of
each specimen were stained. The sections were selected
from the above described sets of 10 slides that allowed
staining of the markers of apoptosis and UPR (n ¼ 8).
Depending on additional stainings (double-immunohisto-
chemistry) and for technical reasons, additional sets of 10
sections adjacent in both directions to the above described
sets were used if needed. Thus, on average, representative
sections stained for each plaque specimen covered a cyl-
inder length of 300e450 mm. All antibodies used in this
study are listed in Table 1 and were used according to the
manufacturer’s instructions and established protocols for
detection of UPR-markers.19,20 Prior to blocking of endog-
enous peroxidase activity with 3% H2O2, antigen retrieval
was performed for cleaved Caspase-3 and ATF-3 (activated
transcription factor 3) by heating for 20 minutes at 95 C in
citrate buffer (pH 6.0) in a waterbath, for CHAC-1 (cation
transport regulator-like protein 1) with pre-digestion in
ready-to-use proteinase K solution (DakoCytomation,
Glostrup, Denmark) for 10 minutes, and for CHOP usingSupplier and Catalog# Concentration
Dako, #M0876 1:50
Sigma, #A2547 1:500
Enzo, #ADI-SPA-827 1:700
Sigma/Atlas, #HPA001562 1:200
Abcam, #ab105101 1:3000
Cell Signaling, #9664 1:100
Santa Cruz, #sc-575 1:50
Table 2. Patient characteristics (n ¼ 10).
Age 73  6 years Range 62e84 years
Male gender 5
n %
Risk factors
Hypertension 10 100
Nicotine abuse 3 30
Hyperlipidemia 6 60
Diabetes mellitus 4 40
Coronary artery disease 3 30
Medication
Statin 5 50
ASS 10 100
Degree of carotid stenosis 88  7% Range 75e99%
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solution (Covance Research Products, USA) in a rice cooker
(20 minutes, 95 C). After blocking with 10% goat normal
serum, the slides were incubated with the primary antibody
for 1 hour at room temperature, followed by a washing step
and incubation with the appropriate HRP-conjugated sec-
ondary antibody (DakoCytomation) for 10 minutes. Reac-
tion products were visualized by incubation in
diaminobenzidine tetrachloride (brown color). Finally, the
slides were counterstained with hematoxylin and mounted
in Fluoromount aqueous mounting medium (Sigma-Aldrich,
St. Louis, MO, USA) or in Entellan (Merck Millipore, Darm-
stadt, Germany). Irrelevant isotype-matched antibodies and
control stainings omitting the primary antibody were used
to exclude non-speciﬁc binding for each antibody, and hu-
man tonsil or pancreas were used as positive controls.
For staining analysis and semiquantitative analysis, one
overview of total cross-sectional area (25 magniﬁcation)
and three representative high-power ﬁelds of the shoulder
region (200magniﬁcation) were captured from each of the
ﬁve sections with a digital camera equipped microscope
(ZEISS Axioplan, Olympus XC30). Semiquantitative analysis of
immunohistochemical stainings was performed by counting
positively stained cells/nuclei in the high-power images by
two independent researchers blinded for patient de-
mographics using freely available ImageJ Software (http://
rsb.info.nih.gov/ij/disclaimer.html).16 For CHAC1, staining
was quantiﬁed as a positively stained area in at least three
representative areas (plaque shoulder, magniﬁcation 200)
of each of ﬁve representative sections using imaging soft-
ware (CellSense, Olympus). Control values were obtained by
quantifying areas of non-diseased internal carotid artery
adjacent to the plaque for each specimen (n¼ 10) as well as
specimens of non-diseased common carotid (n ¼ 3) and
common femoral (n ¼ 3) artery as described above.
Double-immunohistochemistry
For the simultaneous detection of two different antigens
within the same specimen the EnVision Gj2 Doublestain
System visualization kit (DakoCytomation) was used. The
visualization is based on peroxidase (HRP) using DABþ as
chromogen (brown color deposits, KDEL) and alkaline
phosphatase (AP) using Permanent Red as chromogen (red
color deposits, cCaspase-3/CD68/Actin) and were used ac-
cording to the manufacturer’s instructions. All antibodies
used in this assay are detailed in Table 1.
TUNEL-assay
For examining apoptosis by DNA fragmentation, the Apop-
Tag Peroxidase In Situ Apoptosis Detection Kit (Millipore)
was used according to the manufacturer’s instructions. DNA
strand breaks were detected by enzymatically labeling the
free 30-OH termini with modiﬁed nucleotides, and methyl
green was used to counterstain nuclei.
Statistical analysis
Semiquantitative results were presented as indicated and
testing of differences between values was performed usingthe ManneWhitney test (two-tailed). A p value of <.05 was
considered statistically signiﬁcant (*), a p value of <.001
was considered highly signiﬁcant (***).RESULTS
For this study, 10 specimens were selected and the
respective patient characteristics were retrieved from the
computerized database of the Division of Vascular Surgery
of the University Medical Center (Table 2). Analysis of lesion
morphology conﬁrmed that all specimens exhibited features
of rupture-prone plaques corresponding to the inclusion
criteria of this study. The average values for total repre-
sentative cap thickness (all specimen) were 280  60 mm
and for total minimum cap thickness 129  39 mm
(Fig. 1A,B), both being below the cut-off values of 500 mm
and 200 mm, respectively. Selective analysis conﬁrmed that
each specimen had a representative cap thickness of less
than 500 mm (Fig. 1A), and all but one (#5) had a minimum
cap thickness of less than 200 mm (Fig. 1B). The size of the
necrotic core was determined to be 44  7% averaged for
all specimens, and by selective analysis all specimens were
again demonstrated to have a necrotic core size of at least
25% (Fig. 1C). When criteria of the Stary-classiﬁcation were
applied, three specimens could be classiﬁed into Stary
group IV (atheroma with necrotic core) and seven into Stary
group VI (lesion with surface defect).
Immunohistochemistry was used to identify markers of
apoptosis (cleaved Caspase-3 and TUNEL) and UPR-
activation (KDEL, ATF3, CHOP, CHAC1) as well as cellular
markers for macrophages (CD68). Fig. 2A shows a panel of
representative stainings at low magniﬁcation to allow
assessment of the whole circumferential cross-sectional
area and spatial distribution of the individual stainings. In
addition, Fig. 2A shows a representative H&E staining that
was used for measurement of lesion morphology. It could
be demonstrated that markers of apoptosis and UPR-
activation showed increased expression in the shoulder
region of the plaque and around the necrotic core. The
appropriate sections of control tissues (common femoral
artery, CFA, common carotid artery, CCA and internal ca-
rotid artery, ICA) as well as the negative and positive
Figure 1. Histology. Ten specimens were sectioned and analyzed
for representative cap thickness (A), minimum cap thickness (B),
and size of necrotic core (C). For each parameter, the red bar in-
dicates the cut-off value for rupture-prone plaque. Values repre-
sent mean  SD of each individual specimen (1e10) and
mean  SD of all specimens (average).
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ysis are depicted in Fig. 2B. For semiquantitative analysis,
high-power magniﬁcations were obtained from those re-
gions and the individual markers were quantiﬁed. A highly
signiﬁcant increase of markers of apoptosis was found, that
is TUNEL (1387  66 cells/mm2) and cleaved Caspase-3
(1923  93 cells/mm2) in the shoulder region of each pla-
que when compared with control sections (Fig. 3A,B).
In addition, markers of UPR-activation were studied and,
here, robust expression could be demonstrated for markers
of the early UPR-signaling chain like Chaperons GRP 78 and
94 (summarized as KDEL, 1175  40 cells/mm2), ATF3
(1971  69 cells/mm2) as a central signaling molecule of
the PERK-CHOP branch, and CHOP as the canonical pro-apoptotic UPR-effector (2173  120 cells/mm2, Fig. 3Ce
E). Again, expression of the above markers was found to be
signiﬁcantly increased when compared with control
sections.
To provide additional evidence for the activation of CHOP,
CHAC1 was studied, which has been reported to act as a
downstream signaling molecule of CHOP. Here, it was found
that CHAC1 is expressed in the shoulder region (Fig. 4A) and
quantiﬁcation revealed an expression rate of 27  1%,
which was highly signiﬁcant when compared with control
sections (Fig. 4B).
Having shown that both markers of apoptosis and UPR-
activation exhibited signiﬁcantly increased expression in
the plaques, a colocalization analysis was performed. When
adjacent sections were stained for CHOP and TUNEL, both
showed a matching staining pattern (Fig. 5A,B) that was
further corroborated by similar cell counts in semi-
quantitative analysis of positively stained cells (Fig. 5C).
To further corroborate those ﬁndings, double-
immunohistochemistry was performed using antibodies
for KDEL and cleaved Caspase-3. Again, simultaneous
staining of cells with KDEL and cleaved Caspase-3 was
demonstrated indicating presence of UPR-activation (ER-
stress) in apoptotic cells (Fig. 5D,E). To further elucidate the
cell type being involved, co-expression of UPR-marker KDEL
with markers for smooth muscle cells and macrophages was
analyzed. Using double-immunohistochemistry for KDEL and
a-Actin/CD68, it was demonstrated that UPR-activation
occurs only to a small extent in smooth muscle cell-rich
areas (Fig. 5F), but predominantly in macrophage-rich
areas (Fig. 5G).
When plaque apoptosis and UPR-activation were corre-
lated with patient demographics, men showed a signiﬁcant
increase in plaque apoptosis (TUNEL, p ¼ .004) and UPR-
activation (KDEL and CHOP: p < .0001, ATF3: p ¼ .09)
when compared with women. There was no age difference
between men and women (median age 74 vs. 72 years,
range 62e81 vs. 68e84 years, 95% CI 65e82 vs. 66e81
years, p ¼ n.s.). Furthermore, patients on statin medication
had a signiﬁcant higher level of plaque apoptosis (TUNEL
and cleaved Caspase-3, p < .001) when compared with
patients not taking statins. Markers of UPR-activation,
however, were not affected by statin medication (KDEL:
p ¼ .85, AFT3: p ¼ .85, CHOP: p ¼ .25). For both factors
(male gender and statin medication), parameters of plaque
morphology (representative plaque thickness, minimum
plaque thickness and size of necrotic core) were statistically
similar compared with female gender (p ¼ .42, p ¼ .10 and
p ¼ .42, respectively) and no statin medication (p ¼ .55,
p ¼ .31 and p ¼ .31, respectively). With regards to clinical
symptoms, a comparison of parameters for plaque
morphology (representative and minimum cap thickness
and size of necrotic core), lesional apoptosis (cleaved
Caspase-3) and UPR-activation (KDEL, ATF3, CHOP) showed
no signiﬁcant difference between asymptomatic (n ¼ 3)
and symptomatic (n ¼ 7) patients (p ¼ .38, p ¼ .38,
p ¼ .83, p ¼ .27, p ¼ .12, p ¼ .67 and p ¼ .33,
respectively).
Figure 2. Immunohistochemistry. (A) View of total cross-sectional area of a representative specimen showing staining for morphological
analysis (H&E) and immunohistochemistry of markers of apoptosis (cleaved Caspase-3, TUNEL) and UPR-activation (KDEL, ATF3, CHOP,
CHAC1) (magniﬁcation 50, scale bar indicates 500 mm). (B) Stainings of representative sections of control tissues as well as negative/
positive controls for each antibody used for semiquantitative analysis. Control tissues are common femoral artery (CFA), common carotid
artery (CCA), and internal carotid artery adjacent to the plaque (ICA). Negative controls (NC, irrelevant isotype-matched antibody) and
positive controls (PC, Tonsil for TUNEL and cleaved Caspase-3, Pancreas for UPR-markers) are also shown (all magniﬁcations 400).
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Figure 3. Semiquantitative analysis of apoptosis and UPR-markers. A representative image (magniﬁcation 200), and the results of the
quantiﬁcation (bar graph) are shown for each marker of apoptosis (TUNEL, A, and cleaved Caspase-3, B) and activation of UPR (KDEL,
C, ATF3, D, and CHOP, E). Control specimens are common femoral artery (CFA), common carotid artery (CCA), and internal carotid artery
adjacent to the plaque (ICA). Values represent mean  SEM of positively stained cells per mm2. p < .001 for plaque versus all controls
(***).
European Journal of Vascular and Endovascular Surgery Volume 48 Issue 3 p. 248e257 September/2014 253
Figure 4. Semiquantitative analysis of CHAC1. A representative section is shown for quantiﬁcation of CHAC1 (A, magniﬁcation 200). As
CHAC1 staining characteristics comprised cellular (arrow) as well as necrotic core (asterisk) patterns, quantiﬁcation was achieved by
measuring the positively stained area (B). Control specimens are common femoral artery (CFA), common carotid artery (CCA), and internal
carotid artery adjacent to the plaque (ICA). Values are given as mean  SEM of percent of CHAC1-positive stained area of total image area.
p < .001 for plaque versus all controls (***).
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Although the underlying pathomechanisms that govern
plaque disruption in both the coronary and the carotid ar-
teries share similarities,21 different cut-off values have been
described, which deﬁne the “rupture-prone” plaque. The
Oxford plaque study found that critical cap thickness is
greater in carotid plaques than in coronary plaques with a
minimum cap thickness of less than 200 mm and a repre-
sentative cap thickness of less than 500 mm.17 A lipid core
size of less than 25% of cross-sectional area was identiﬁed
as one of the predominant histologic features in ruptured
carotid plaques.2
Consequently, for the present study the focus was on
advanced carotid plaques and included only study specimen
that fulﬁlled the three parameters of ruptured/rupture-
prone carotid plaques (minimum cap thickness <200 mm,
representative cap thickness <500 mm, necrotic core
>25%). The majority (seven) of the specimens were
complicated plaques (Stary VI) with surface ﬁssure/rupture,
the other three were advanced plaques (Stary IV), a ratio
that has also been found in other studies examining culprit
lesions.22
In those specimens, a signiﬁcant increase of apoptosis as
a key-stone element of plaque progression towards rupture
could be demonstrated by immunohistochemical detection
of cleaved Caspase-3 and DNA strand breaks (TUNEL) in
comparison with control specimens. For evaluation of
activation of the UPR, the focus was on three well-
established signaling molecules involved in the proapopto-
tic PERK-CHOP branch: Chaperones GRP78 and GRP94
(recognized by the c-terminal retention sequence
KDEL11,16,19), ATF320,23,24 and CHOP.7,14,16,19 Using semi-
quantitative analysis of immunohistochemical detection of
KDEL, ATF3 and CHOP, it was shown that expression of all
three signaling molecules is robust and signiﬁcantly
increased in plaques when compared with control tissue
(common femoral, common carotid, and non-diseased in-
ternal carotid artery).
Those ﬁndings are in line with results obtained from an
analysis of 16 human coronary atherectomy specimens of
patients where a signiﬁcant increase in KDEL- and CHOP-positive cells in patients with unstable angina versus sta-
ble angina was documented.16
In addition to the work of Myoishi et al., which so far is
the only available study on human tissue, convincing evi-
dence from genetically modiﬁed atherogenic mouse models
(ApoE/) exists wherein a signiﬁcant increase in the
expression of KDEL and CHOP in lesions could be docu-
mented.11,15 Vice versa, by using a combined CHOP/
ApoE/ deﬁcient mouse model, a signiﬁcant reduction of
UPR-activation (GRP78) and plaque size,12 as well as a sig-
niﬁcant reduction of lesional apoptosis (TUNEL-positive
cells) was shown.13,14
To corroborate the above ﬁndings of UPR-activation,
additive evidence of increased CHOP expression was eval-
uated, that is the key element of the proapoptotic UPR-
branch, CHAC-1 (cation transport regulator-like protein 1),
has been identiﬁed to act as a proapoptotic component of
the UPR downstream of CHOP.20,23,24 It was shown that
CHAC1 expression is signiﬁcantly increased in plaques when
compared with control tissue.
Colocalization analysis conﬁrmed that markers of UPR-
activation and apoptosis can be detected in close prox-
imity at the cellular level, and it was shown that UPR-
activation can be predominantly localized in lesional mac-
rophages and, to a lesser extent, smooth muscle, which
again is in line with ﬁndings obtained by other groups.14e16
In addition, analysis of plaque apoptosis revealed a sig-
niﬁcant effect of statin therapy and supports ﬁndings of
apoptosis induction in vascular cells by HMG-CoA reductase
inhibitors.25 A potential inﬂuence of gender was also seen
in this study, with increased apoptosis and UPR-activation in
male patients that may be attributed to increased suscep-
tibility of men to inﬂammatory processes. However, the
mean age in this study was 73 years and the role of gender
differences related to postmenopausal hormone changes
(estrogen) remains controversial.26
Taken together, specimens were selected in this study
that fulﬁlled morphologic criteria of rupture-prone carotid
plaques and it was shown that activation of the proapo-
ptotic CHOP-branch of the UPR occurs in lesional macro-
phages, and to a lesser extent smooth muscle cells, and
Figure 5. Colocalization analysis. Staining for CHOP (A) and TUNEL (B) of adjacent sections is shown (magniﬁcation 200). (C) Semi-
quantitative analysis of CHOP and TUNEL in ﬁve pairs of adjacent sections. To assess colocalization of apoptosis and UPR-activation in the
same section, double immunohistochemistry was performed (cleaved Caspase-3, brown pigment and KDEL, red pigment) and shown as
high-power magniﬁcation (200, D and 400, E) of two representative specimens. Representative arrows (black) indicate positively
stained cells for cleaved Caspase-3 and KDEL. Colocalization analysis of UPR-activation (KDEL, brown pigment) with smooth muscle cells (F,
red pigment) and macrophages (G, red pigment) was performed using double immunohistochemistry. For smooth muscle cells (F) a-actin
was used, and for macrophages (G) CD68 was used as antigen (both magniﬁcations 100).
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256 B. Dorweiler et al.colocalizes with markers of apoptosis. To the authors’
knowledge, this is the ﬁrst study examining UPR-activation
in human carotid plaques and the ﬁndings ﬁt well with
results obtained from human coronary plaques and data
from atherogenic mice models highlighting ER-stress and
the UPR as a potential and potent inducer of apoptosis of
vascular cells and thereby contributing to plaque progres-
sion and rupture.
Potential limitations of this study include the lack of
multivariate regression analysis to identify potential in-
ﬂuences on apoptosis and UPR-activation related to the
number of specimens analyzed. Furthermore, in this pilot
study, a correlation was performed between plaque
morphology and individual clinical status (symptomatic vs.
asymptomatic), which yielded no signiﬁcant difference be-
tween the groups. Of note, the actual number of specimens
in the asymptomatic group was low (n ¼ 3) and there are
controversial reports on the validity of such a correla-
tion.22,27 Furthermore, the current clinical deﬁnition of a
“symptomatic” carotid stenosis covers a wide time interval
of up to 6 months after the onset of neurological symp-
toms. In the present study, “symptomatic” specimens
showed a considerable variation in time from insult to
operation, of between 1 and 35 days. However, it is realized
that correlation of clinical status with UPR-activation in a
study enrolling a larger specimen series of both asymp-
tomatic and symptomatic stenoses with short interval from
onset of symptoms to operation (<7 days), may provide
additional insight and should be addressed in a future study.
Thirdly, owing to the indication for operative endarterec-
tomy (high-grade stenosis), it was not possible to include a
control group of early stages of plaque development
(moderate stenosis). Therefore, there is the possibility that
the activation of apoptosis and UPR observed under the
study conditions may also be a response to plaque
remodeling rather than an actual cause of plaque rupture.
Putting the results into perspective, acute cerebrovascular
events (stroke and TIA) may now be considered as the clinical
events together with acute coronary syndromes that warrant
intense research into development and implementation of
anti-apoptotic strategies. Targeting activation of the UPR-
PERK/CHOP-branch speciﬁcally may serve as a potential
mechanism to relieve ER-induced apoptosis, and thereby
reduce acute events/plaque ruptures in cardiovascular dis-
ease. However, because of the complexity of the UPR-
signaling network and its fundamental role in cellular ho-
meostasis (protein synthesis) and survival, further work is
needed to understand the interplay of the UPR effectors and
dissect elements with the most promising therapeutic gain.
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